[D-Ala6]-LH-RH acetate salt hydrate
SIGMA/L1898 - ≥97% (HPLC)
Synonym: (D-Ala-6) Luteinizing Hormone Releasing Hormone
Empirical Formula (Hill Notation): C56H77N17O13 · xC2H4O2 · yH2O
Molecular Weight: 1196.32 (anhydrous free base basis)
Linear Formula: C56H77N17O13 · xC2H4O2 · yH2O
Product Type: Chemical
| assay | ≥97% (HPLC) |
| composition | Peptide content, ≥65% |
| InChI | 1S/C56H77N17O13.C2H4O2.H2 |
| InChI key | KGUIXKYKIZMKMT-JGUOWLKQSA |
| Quality Level | 200 ![]() |
| SMILES string | [H]O[H].CC(O)=O.CC(C)C[C@ |
| storage temp. | −20°C |
| UniProt accession no. | P01148 ![]() |
| Amino Acid Sequence: | Glp-His-Trp-Ser-Tyr-Ala-L |
| Application: | [D-Ala6]-LH-RH acetate salt hydrate has been used to induce ovulation and to synchronize the reproductive cycle in Sprague-Dawley female rats. |
| Biochem/physiol Actions: | (D-Ala6)-LH-RH is a GnRH (gonadotropin-releasing hormone) agonist. GnRH, which is also referred to as LHRH (luteinizing hormone-releasing hormone) or gonadorelin, is crucial for mammalian reproduction and is released from hypothalamic neurons. It is responsible for the secretion of gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from pituitary glands. Mutations in GnRH are associated with normosmic congenital hypogonadotropic hypogonadism. |
| Biochem/physiol Actions: | Potent LH-RH agonist. |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360 |
| Precautionary statements | P201 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 60 |
| Safety Statements | 53-22-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352209 |


